首页> 美国政府科技报告 >Calprotectin as a biomarker for melioidosis disease progression and management.

【24h】

Calprotectin as a biomarker for melioidosis disease progression and management.

机译：钙卫蛋白作为类鼻疽病进展和管理的生物标志物。

获取原文

页面导航

摘要
著录项
相似文献
相关主题

摘要

No abstract available

著录项

作者
Liang, J.; Jangra, R. K.; Radoshitzky, S. R.; Wada, J.; Bollinger, L.; Chandran, K.; Kuhn, J. H.; Jensen, K. S.;
展开▼
作者单位

展开▼
年度 2017
页码 1-35
总页数 35
原文格式 PDF
正文语种 eng
中图分类
关键词
Marbug virus; Melioidosis disease progression;

机译：marbug病毒; melioidosis疾病进展;

相似文献

外文文献
中文文献
专利

1. 迈向精准医学:液体活检中5-羟甲基胞嘧啶类癌症生物标志物发现的研究进展 [J] . Chang Zeng, Emily Kunce Stroup, Zhou Zhang, 癌症（英文版） . 2019,第010期
2. Erratum: EMerging BiomARKers in inflammatory bowel disease (EMBARK) study identifies fecal calprotectin, serum MMP9, and serum IL-22 as a novel combination of biomarkers for crohn's disease activity: Role of cross-sectional imaging (American Journal of Gastroenterology (2013) 108 (1891-1900) DOI: 10.1038/ajg.2013.354) [J] . FaubionW.A., FletcherJ.G., OByrneS., The American Journal of Gastroenterology . 2014,第5期

机译：勘误表：在炎症性肠病中出现新兴生物mARKers（EMBARK）研究发现粪便钙卫蛋白，血清MMP9和血清IL-22是克罗恩病活性的生物标志物的新组合：横断面成像的作用（美国胃肠病学杂志（2013）108 （1891-1900）DOI：10.1038 / ajg.2013.354）
3. Emerging biomarkers in inflammatory bowel disease (embark) study identifies fecal calprotectin, serum mmp9, and serum il-22 as a novel combination of biomarkers for crohn's disease activity: Role of cross-sectional imaging [J] . FaubionW.A., FletcherJ.G., OByrneS., The American Journal of Gastroenterology . 2013,第12期

机译：炎症性肠病（腹部）研究中的新兴生物标志物将粪便钙卫蛋白，血清mmp9和血清il-22鉴定为克罗恩病活性的生物标志物的新型组合：横截面成像的作用
4. Letter: Faecal calprotectin and lactoferrin - Accurate biomarkers in post-operative Crohn's disease - Authors' reply: Letter: biologic therapies are effective for prevention of post-operative Crohn's disease recurrence - Authors' reply [J] . JonesG.R., KennedyN.A., LeesC.W., Alimentary pharmacology & therapeutics. . 2014,第3期

机译：信件：粪便钙卫蛋白和乳铁蛋白-克罗恩病术后的准确生物标志物-作者的答复：信件：生物疗法可有效预防克罗恩病术后复发-作者的答复
5. Quantifiction of Biomarkers for Anthrax to Understand the Progression of the Progression of the Disease and Toxemia [C] . John R. Barr, Anne E. Boyer, Maribel Gallegos-Candela, American Society for Mass Spectrometry Conference on Mass Spectrometry and Allied Topics . 2012

机译：量化炭疽病患者，了解疾病和毒性进展的进展
6. Muscle biomarkers of type 2 diabetes disease progression in Goto-Kakizaki rats. [D] . Nie, Jing. 2010

机译：后藤崎崎大鼠中2型糖尿病疾病进展的肌肉生物标志物。
7. Calprotectin as a Biomarker for Melioidosis Disease Progression and Management [O] . Mohan Natesan, Enoka Corea, Shivankari Krishnananthasivam, 2017

机译：钙卫蛋白作为类痔病疾病进展和管理的生物标志物
8. Fibulin-3 and other cartilage metabolism biomarkers in relationship to calprotectin (MRP8/14) and disease activity in rheumatoid arthritis patients treated with anti-TNF therapy [O] . Magdalena Kopec-Medrek, Eugene Kucharz 2018

机译：与抗TNF治疗治疗的CalProtectin（MRP8 / 14）和疾病活性的菌丝蛋白-3和其他软骨代谢生物标志物及其疾病活性
9. Calprotectin as a biomarker for melioidosis disease progression and management. [R] . Natesan, M. 2017

机译：钙卫蛋白作为类鼻疽病进展和管理的生物标志物。

Calprotectin as a biomarker for melioidosis disease progression and management.

摘要

著录项

相似文献

相关主题

期刊订阅